Recently, Schäcke et al. [15] reported the pharmacological characterization of mapracorat (also known as BOL-303242-X or ZK 245186), a nonsteroidal selective glucocorticoid receptor agonist, for the topical treatment of inflammatory skin disorders. The gene discussed is NR3C1; the disease is inflammatory skin disease.